Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-20

FDA Approved: PROBENECID — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved Rising Pharma Holdings' original application for a generic probenecid product. Probenecid is a uricosuric agent used to treat gout and hyperuri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probenecid (probenecid)

Snippet

ORIG AP for PROBENECID (PROBENECID)